88 related articles for article (PubMed ID: 11326693)
1. Serum levels of prostate specific antigen in men on hemodialysis.
Wolff JM; Ting O; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):5191-3. PubMed ID: 11326693
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of total and free prostate specific antigen in men on hemodialysis.
Sasagawa I; Kubota Y; Hayami S; Adachi M; Nakada T; Miura H; Imai K
J Urol; 1998 Jul; 160(1):83-5. PubMed ID: 9628610
[TBL] [Abstract][Full Text] [Related]
3. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
Passadakis P; Ersoy F; Tam P; Memmos D; Siamopoulos K; Ozener C; Akçiçek F; Camsari T; Ates K; Ataman R; Vlachojannis J; Dombros N; Utas C; Akpolat T; Bozfakioglu S; Wu GG; Karayaylali I; Arinsoy T; Stathakis C; Yavuz M; Tsakiris D; Dimitriades A; Yilmaz ME; Gültekin M; Karayalçin B; Challa A; Polat N; Oreopoulos DG
Adv Perit Dial; 2004; 20():203-8. PubMed ID: 15384827
[TBL] [Abstract][Full Text] [Related]
5. Age related changes of free and total prostate specific antigen in serum.
Wolff JM; Borchers H; Rohde D; Jakse G
Anticancer Res; 1999; 19(4A):2629-32. PubMed ID: 10470207
[TBL] [Abstract][Full Text] [Related]
6. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
Irani J; Salomon L; Soulié M; Zlotta A; de la Taille A; Doré B; Millet C
Urology; 2005 Mar; 65(3):533-7. PubMed ID: 15780371
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer screening with prostate-specific antigen in hemodialysis patients.
Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T
Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492
[TBL] [Abstract][Full Text] [Related]
8. Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL.
Kravchick S; Peled R; Dorfman D; Agulansky L; Ben-Dor D; Cytron S
Urology; 2005 Sep; 66(3):542-6. PubMed ID: 16140074
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
[TBL] [Abstract][Full Text] [Related]
11. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
12. Effect of NIH-IV prostatitis on free and free-to-total PSA.
Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
[TBL] [Abstract][Full Text] [Related]
13. Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men.
Ayatollahi H; Darabi Mahboub MR; Mohammadian N; Parizadeh MR; Kianoosh T; Khabbaz Khoob M; Kamalian F
Urol J; 2007; 4(4):238-41. PubMed ID: 18270950
[TBL] [Abstract][Full Text] [Related]
14. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
[TBL] [Abstract][Full Text] [Related]
15. Shift of the f/t-PSA quotient in relation to renal insufficiency: consequences for the early detection of prostate carcinoma in patients with terminal renal failure.
Fischer K; Hamza A; Wicht A; Loertzer H; Fornara P
Anticancer Res; 2007; 27(4A):1945-8. PubMed ID: 17649801
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection by prostate-specific antigen-related parameters.
Segawa N; Gohji K; Iwamoto Y; Ueda H; Katsuoka Y
Hinyokika Kiyo; 2003 Jul; 49(7):405-10. PubMed ID: 12968483
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
18. Effects of renal transplantation on serum-free and total PSA levels.
Kamali K; Zargar MA
Transplant Proc; 2007 May; 39(4):1027-8. PubMed ID: 17524882
[TBL] [Abstract][Full Text] [Related]
19. [The percentage of free prostate specific antigen used in detecting prostate cancer].
Yang L; Fang Z; Song J; Deng S
Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):47-9. PubMed ID: 11829778
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.
Khan MA; Partin AW; Rittenhouse HG; Mikolajczyk SD; Sokoll LJ; Chan DW; Veltri RW
J Urol; 2003 Sep; 170(3):723-6. PubMed ID: 12913682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
